1017-71 Patient-Specific Heparin Dosing During Angioplasty
Journal of The American College of Cardiology(1995)
摘要
The risk of ischemic events and bleeding complications during angioplasty is related to the intensity of heparin anticoagulation as monitored by the activated clotting time (ACT). Data on patient characteristics that affect the dosing of heparin during angioplasty to achieve a desired target ACT is limited. The Hemochron ACT was measured 10 minutes after a heparin bolus in 438 non-emergency angioplasty patients. The influence of heparin dose, patient age, weight. gender, presenting diagnosis, and pre-procedural continuous intravenous heparin use on the intensity of anticoagulation achieved were examined with univariate followed by stepwise multivariate regression analysis.
Univariate Multivariate
critical value p-value critical value p-value
Age 0.034 ns
Weight -2.15 0.033 -2925 <0.001
Female Gender 1.21 0.34
Unstable Angina -2.04 0.043 -0.069 ns
Pre-procedural IV Heparin -538 <0.001 -2.39 0023
Heparin Dose 635 <0.001 8.95 <0.001
Full-size table
Table options
View in workspace
Download as CSV
Conclusions
Patient weight, pre-procedural IV heparin therapy, and heparin dose were significant independent predictors of the ACT achieved, Preprocedural intravenous heparin significantly increased the heparin dose required to achieve the target ACT, suggesting the development of tolerance to heparin. Similarly, patients with unstable angina required significantly more heparin to achieve the target ACT Recognition of these factors allows patient-specific heparin dosing during angioplasty. A nomogram for patients receiving pre-procedural heparin therapy, for example, shows the relationship between patient weight. heparin dose, and the expected target ACT.
Figure options
Download full-size image
Download high-quality image (66 K)
Download as PowerPoint slide
更多查看译文
关键词
heparin,angioplasty,patient-specific
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要